WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010028108) STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/028108    International Application No.:    PCT/US2009/055820
Publication Date: 11.03.2010 International Filing Date: 03.09.2009
IPC:
A61K 9/20 (2006.01), A61K 31/00 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000 Route 206 and ProvinceLine Road Princeton, New Jersey 08543-4000 (US) (For All Designated States Except US).
BROWN, Jonathan, R. [GB/GB]; (GB) (For US Only).
TOALE, Helen [GB/GB]; (GB) (For US Only).
DENNIS, Andrew, B. [GB/GB]; (GB) (For US Only).
TIMMINS, Peter [GB/GB]; (GB) (For US Only)
Inventors: BROWN, Jonathan, R.; (GB).
TOALE, Helen; (GB).
DENNIS, Andrew, B.; (GB).
TIMMINS, Peter; (GB)
Agent: LEVIS, John, F.; (US)
Priority Data:
61/094,131 04.09.2008 US
Title (EN) STABLE PHARMACEUTICAL COMPOSITION FOR OPTIMIZED DELIVERY OF AN HIV ATTACHMENT INHIBITOR
(FR) COMPOSITION PHARMACEUTIQUE STABLE POUR L'ADMINISTRATION OPTIMISÉE D'UN INHIBITEUR DE LA FIXATION DU VIH
Abstract: front page image
(EN)A pharmaceutical composition contains the compound 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, and hydroxypropyl methyl cellulose (HPMC) having a viscosity of at least about 100 cP, wherein the composition does not contain any enzyme inhibitors.
(FR)L'invention porte sur une composition pharmaceutique qui contient le composé 1-benzoyl-4-[2-[4-méthoxy-7-(3-méthyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)méthyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoéthyl]-pipérazine, et de l'hydroxypropyl méthyl cellulose (HPMC) ayant une viscosité d'au moins environ 100 cP, la composition ne contenant pas d'inhibiteurs d'enzymes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)